From research to the market: FORUM Science & Health presents groundbreaking developments for a medicine of the future

FORUM Science & Health conference: Topics on "Medicine of the Future" © BioM

Around 200 participants accepted the invitation to the Veranstaltungsforum Fürstenfeldbruck. The network organization BioM Biotech Cluster Management GmbH invited to the third interdisciplinary conference FORUM Science & Health on July 05 and 06, 2022, to discuss the future of medicine with politicians, high-ranking speakers from research, clinical and biotechnology industry. At the press conference, the latest figures and developments of the new "Bavarian Biotech Report 2021/22" were presented. Overall, the biotechnology industry continues to be dynamic in terms of start-ups and financing and stable as a major employer in Bavaria.

The congress was organized for the third time by BioM on behalf of the StMWi. Representing the StMWi, Dr. Ulrike Wolf, Ministerial Director at the Bavarian State Ministry of Economic Affairs, Regional Development and Energy (StMWi) welcomed the audience and the nearly 60 high-ranking speakers, including Prof. emerit. Ernst-Ludwig Winnacker, father of the Munich Gene Center, Prof. Heyo Kroemer, Chief Executive Officer of Charité Berlin, and Prof. Patrick Cramer, current Director at the Max Planck Institute for Multidisciplinary Natural Sciences in Göttingen, and congratulated Prof. Cramer on behalf of the Bavarian State Government on his recent election as the new President of the renowned Max Planck Society.

She praised the congress as an important meeting place for science and industry in the field of biotechnology: "Over the next two days, the latest developments in innovative technologies and therapeutics will be presented here. What we can see here will have a major impact on how diseases are diagnosed and treated in the future, and not least how they can be prevented."

The FORUM Science & Health is the interdisciplinary meeting point in Bavaria for all those interested in life science and biotechnology and connects players from the fields of biotechnology, medicine, nutrition, medical technology and digitization in order to set new impulses for a future-oriented integrated medicine. Various formats provided information on current developments in the industry, new technologies, groundbreaking findings and topics in health research.

Bavaria's Secretary of State for Economic Affairs Roland Weigert underlined the importance of the congress in his digital greeting and highlighted the innovative power of Bavaria as a business location: "The FORUM Science & Health is the meeting place for Bavaria's players from life science, biotech, digitization, medicine and medical technology. It offers excellent opportunities for the exchange of ideas, networking and intensive discussion of new technologies and findings in medical research. Bavaria is a highly attractive region for innovations and productive collaborations between business, science and research. Our goal is to vigorously drive new trends and groundbreaking innovations for the medicine of the future."

Presentations highlighted the potential of mRNA for diagnostics and therapies, discussed the possibilities of Big Data, e.g. for high-throughput screening procedures, and presented nanotechnologies in use for drug development and diagnostics. The panel discussion on day 2 provided an outlook on how a medicine of the future can protect against future health threats: Innovative approaches to combat antibiotic resistance, different therapeutic COVID-19 approaches to efficiently fight infection, and the impact of lifestyle adaptations and changing environmental conditions for healthy living.

On the second day of the FORUM, the latest figures of the "Bavarian Biotech Report 2021/22" were presented furthermore by BioM CEO Prof. Horst Domdey in a press conference. He shed light on the developments and general conditions of the Bavarian biotech scene with two discussion partners from science and the clinic: Prof. Clemens Wendtner, Senior Medical Director of Infectiology at the Munich Clinic Schwabing and Dr. Hitto Kaufmann, Chief Scientific Officer of the Munich-based biotech company Pieris Pharmaceuticals.

The FORUM Science & Health concluded with a livetalk roundtable on "Precision Medicine: The Opportunity of Early Diagnosis", streamed live from the Fürstenfeld event forum. Prof. Eva Susanne Dietrich from Rheinische Friedrich-Wilhelms-Universität Bonn, Dr. Hanns-Georg Klein from MVZ Martinsried, Prof. Wolfgang Kern from MLL Munich Leukemia Laboratory and Prof. Matthias H. Tschöp from Helmholtz Munich discussed the opportunities presented by new biomarkers, innovative imaging techniques, Big Data and the use of AI from scientific, medical, ethical and economic perspectives.

These and other Livetalk episodes can be accessed here. The next FORUM Science & Health event is planned for 2024.